Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
350
mi
from 43215
Springfield, IL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Springfield Clinic - Clinical Research
350
mi
from 43215
Springfield, IL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
1654
mi
from 43215
Phoenix, AZ
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Arizona Arthritis & Rheumatology Associates, PC
1654
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
751
mi
from 43215
Daytona Beach, FL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Allergy, Asthma, Arthritis, & Lung
751
mi
from 43215
Daytona Beach, FL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
798
mi
from 43215
New Orleans, LA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Louisiana State University Health Sciences Center
798
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
176
mi
from 43215
Bingham Farms, MI
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
QUEST Research Institiute
176
mi
from 43215
Bingham Farms, MI
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
436
mi
from 43215
Jackson, TN
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
West Tennessee Research Institute
436
mi
from 43215
Jackson, TN
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
2031
mi
from 43215
Fair Oaks, CA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Med Investigations
2031
mi
from 43215
Fair Oaks, CA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
2030
mi
from 43215
Roseville, CA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Office of Anupama Bhat, MD
2030
mi
from 43215
Roseville, CA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
792
mi
from 43215
Orlando, FL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Dr. Jeffrey E. Poiley, MD , Office of
792
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
997
mi
from 43215
South Miami, FL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Arthritis and Rheumatic Care Center
997
mi
from 43215
South Miami, FL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
300
mi
from 43215
Frederick, MD
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Arthritis Treatment Center
300
mi
from 43215
Frederick, MD
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
5385
mi
from 43215
Buenos Aires,
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
OMI- Organizacion Medica de Investigacion
5385
mi
from 43215
Buenos Aires,
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
834
mi
from 43215
Saint Petersburg, FL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Suncoast Medical Clinic
834
mi
from 43215
Saint Petersburg, FL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
830
mi
from 43215
Tampa, FL
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
BayCare Medical Group, Inc.
830
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
324
mi
from 43215
Wheaton, MD
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
The Center for Rheumatology and Bone Research
324
mi
from 43215
Wheaton, MD
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
136
mi
from 43215
Mayfield, OH
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Office of David R. Mandel, MD, Inc.
136
mi
from 43215
Mayfield, OH
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
1988
mi
from 43215
Vancouver, WA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
The Vancouver Clinic, Inc, PS
1988
mi
from 43215
Vancouver, WA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
505
mi
from 43215
Jonesboro, AR
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
NEA Baptist Clinic
505
mi
from 43215
Jonesboro, AR
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
1982
mi
from 43215
Los Angeles, CA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Ronald Reagan UCLA Medical Center - Drug Information Center
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
433
mi
from 43215
Decatur, GA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Jeffrey D. Lieberman, MD, PC
433
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
1716
mi
from 43215
Boise, ID
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
St. Luke's Clinic - Rheumatology
1716
mi
from 43215
Boise, ID
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
1713
mi
from 43215
Boise, ID
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
St. Luke's Intermountain Research Center
1713
mi
from 43215
Boise, ID
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
176
mi
from 43215
Southfield, MI
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Farmbrook Radiology Associates
176
mi
from 43215
Southfield, MI
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
605
mi
from 43215
Massachusetts, NE
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology Study Group
605
mi
from 43215
Massachusetts, NE
Click here to add this to my saved trials
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
2006
mi
from 43215
Seattle, WA
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
A Long-term, Open-label Follow-up Study Of Tofacitinib (Cp-690,550) For Treatment Of Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Seattle Rheumatology Associates
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Ankle Joint Replacement Outcomes Study
Salto Talaris Anatomic Ankle Arthroplasty Outcomes Study
Status: Enrolling
Updated:  12/31/1969
330
mi
from 43215
Milwaukee, WI
Ankle Joint Replacement Outcomes Study
Salto Talaris Anatomic Ankle Arthroplasty Outcomes Study
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
330
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
Ankle Joint Replacement Outcomes Study
Salto Talaris Anatomic Ankle Arthroplasty Outcomes Study
Status: Enrolling
Updated:  12/31/1969
1138
mi
from 43215
San Antonio, TX
Ankle Joint Replacement Outcomes Study
Salto Talaris Anatomic Ankle Arthroplasty Outcomes Study
Status: Enrolling
Updated: 12/31/1969
Foot and Ankle Center of South Texas
1138
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Duke Autoimmunity in Pregnancy Registry
Duke Autoimmunity in Pregnancy Registry
Status: Enrolling
Updated:  12/31/1969
352
mi
from 43215
Durham, NC
Duke Autoimmunity in Pregnancy Registry
Duke Autoimmunity in Pregnancy Registry
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated:  12/31/1969
270
mi
from 43215
Chicago, IL
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated: 12/31/1969
University of Chicago
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated:  12/31/1969
138
mi
from 43215
Cleveland, OH
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated: 12/31/1969
University Hospitals at Case Medical Center
138
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated:  12/31/1969
123
mi
from 43215
Cleveland, OH
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated: 12/31/1969
Metrohealth
123
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated:  12/31/1969
129
mi
from 43215
Cleveland, OH
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
Pilot Study of the Safety and Efficacy of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Female Subjects With Juvenile Idiopathic Arthritis (JIA)/ Seronegative Arthritis
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic
129
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
Status: Enrolling
Updated:  12/31/1969
821
mi
from 43215
Palm Harbor, FL
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
Status: Enrolling
Updated: 12/31/1969
Arthritis Research of Florida, Inc.
821
mi
from 43215
Palm Harbor, FL
Click here to add this to my saved trials
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
Status: Enrolling
Updated:  12/31/1969
822
mi
from 43215
Tampa, FL
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis.
Status: Enrolling
Updated: 12/31/1969
University of South Florida
822
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
1642
mi
from 43215
Tucson, AZ
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Tucson Orthopaedic Institute
1642
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
884
mi
from 43215
Lake Charles, LA
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Center for Orthopaedics
884
mi
from 43215
Lake Charles, LA
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
480
mi
from 43215
New York, NY
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Hospital for Special Surgery
480
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
354
mi
from 43215
Rochester, NY
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Univ of Rochester Medical Center
354
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
350
mi
from 43215
Charlotte, NC
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
OrthoCarolina
350
mi
from 43215
Charlotte, NC
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
327
mi
from 43215
Alexandria, VA
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Anderson Orthopaedic Clinic
327
mi
from 43215
Alexandria, VA
Click here to add this to my saved trials
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated:  12/31/1969
344
mi
from 43215
Grafton, WI
A Safety and Efficacy Study of the Birmingham Hip Resurfacing System
Birmingham Hip Resurfacing System (BHR) Post Approval Study: A Prospective, Multi-Centered Study of the Birmingham Hip Resurfacing System
Status: Enrolling
Updated: 12/31/1969
Aurora Medical Center
344
mi
from 43215
Grafton, WI
Click here to add this to my saved trials
Hip Osteoarthritis: Effects of Exercise Programs on Pain and Disability
Hip Osteoarthritis: Effects of Structured Exercise Programs on Pain and Long-term Disability
Status: Enrolling
Updated:  12/31/1969
2027
mi
from 43215
Portland, OR
Hip Osteoarthritis: Effects of Exercise Programs on Pain and Disability
Hip Osteoarthritis: Effects of Structured Exercise Programs on Pain and Long-term Disability
Status: Enrolling
Updated: 12/31/1969
Oregon Health & Science University Center for Health & Healing
2027
mi
from 43215
Portland, OR
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Phoenix, AZ
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
AZ Arthritis and Rheum Researc /ID# 21023
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Tucson, AZ
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Catalina Pointe Clinical Res /ID# 40227
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
623
mi
from 43215
Little Rock, AR
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Arkansas Children's Hospital /ID# 23505
623
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Los Angeles, CA
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital LA /ID# 24386
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Washington,
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Children's Natl Med Ctr /ID# 23506
mi
from 43215
Washington,
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
949
mi
from 43215
Delray Beach, FL
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Arthritis Associates South FL /ID# 17001
949
mi
from 43215
Delray Beach, FL
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Chicago, IL
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital of Chicago /ID# 20966
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
mi
from 43215
Chicago, IL
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
University of Chicago /ID# 21981
mi
from 43215
Chicago, IL
Click here to add this to my saved trials